JP2023538807A5 - - Google Patents
Info
- Publication number
- JP2023538807A5 JP2023538807A5 JP2023502703A JP2023502703A JP2023538807A5 JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5 JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- sar
- compstatin analog
- acceptable salt
- peg3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20186297 | 2020-07-16 | ||
| EP20186297.6 | 2020-07-16 | ||
| PCT/EP2021/069798 WO2022013374A1 (en) | 2020-07-16 | 2021-07-15 | Inhibitors of complement factor c3 and their medical uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538807A JP2023538807A (ja) | 2023-09-12 |
| JP2023538807A5 true JP2023538807A5 (cg-RX-API-DMAC10.html) | 2024-07-24 |
Family
ID=71661768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502703A Pending JP2023538807A (ja) | 2020-07-16 | 2021-07-15 | 補体因子c3の阻害剤及びそれらの医学的使用 |
Country Status (11)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020017385A2 (pt) | 2018-02-27 | 2020-12-15 | Zp Spv 3 K/S | Análogos de compstatina, métodos e seus usos médicos |
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| EP4622992A1 (en) * | 2022-11-24 | 2025-10-01 | Amyndas Pharmaceuticals US LLC | Compstatin analogs for vector-based therapy |
| CN118812653A (zh) * | 2023-04-18 | 2024-10-22 | 成都奥达生物科技有限公司 | 一种长效坎普他汀化合物 |
| CN119219741A (zh) * | 2023-06-29 | 2024-12-31 | 刘晓蓉 | 新型补体抑制剂及其制备、应用和产品 |
| CN122255228A (zh) * | 2024-12-20 | 2026-06-23 | 重庆派金生物科技有限公司 | 靶向抑制c3与c5补体的双功能多肽、多肽偶联物及它们的应用 |
| US20260234189A1 (en) | 2025-01-24 | 2026-08-13 | Boehringer Ingelheim International Gmbh | Novel and stable compstatin analogues |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000505068A (ja) | 1996-03-13 | 2000-04-25 | トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア | 補体活性化を阻害する新規ペプチド類 |
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| WO1999013899A1 (en) | 1997-09-17 | 1999-03-25 | Trustees Of The University Of Pennsylvania | Peptides and peptidomimetics for inhibiting complement activation |
| US7989589B2 (en) | 2002-09-20 | 2011-08-02 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved activity |
| CN101325963B (zh) | 2005-10-08 | 2016-01-27 | 博泰迪亚制药公司 | 用于眼部病症的补体抑制素和其类似物 |
| ES2390828T3 (es) | 2005-11-28 | 2012-11-16 | The Trustees Of The University Of Pennsylvania | Análogos potentes de la compstatina |
| WO2008153963A1 (en) | 2007-06-08 | 2008-12-18 | The Trustees Of The University Of Pennsylvania | Structure of compstatin-c3 complex and use for rational drug design |
| CA2813049A1 (en) * | 2010-09-23 | 2012-03-29 | The Trustees Of The University Of Pennsylvania | Modified compstatin with improved stability and binding properties |
| EP2751161B1 (en) * | 2011-08-31 | 2018-09-19 | Huntsmann Advanced Materials Licensing (Switzerland) GmbH | Process for the impregnation of air core reactors, impregnated air core reactor and use of an impregnation system |
| PL2753636T3 (pl) | 2011-09-07 | 2020-05-18 | The Trustees Of The University Of Pennsylvania | Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych |
| WO2014100407A1 (en) | 2012-12-19 | 2014-06-26 | The Regents Of The University Of California | Compstatin analogs |
| US10213476B2 (en) * | 2014-03-17 | 2019-02-26 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved potency and pharmacokinetic properties |
| BR112020017385A2 (pt) * | 2018-02-27 | 2020-12-15 | Zp Spv 3 K/S | Análogos de compstatina, métodos e seus usos médicos |
| ES3049784T3 (en) * | 2019-08-27 | 2025-12-18 | Zp Spv 3 K/S | Compstatin analogues and their medical uses |
-
2021
- 2021-07-15 JP JP2023502703A patent/JP2023538807A/ja active Pending
- 2021-07-15 CA CA3185730A patent/CA3185730A1/en active Pending
- 2021-07-15 WO PCT/EP2021/069798 patent/WO2022013374A1/en not_active Ceased
- 2021-07-15 MX MX2023000679A patent/MX2023000679A/es unknown
- 2021-07-15 US US18/016,490 patent/US20230287051A1/en active Pending
- 2021-07-15 KR KR1020237005557A patent/KR20230039718A/ko not_active Ceased
- 2021-07-15 IL IL299870A patent/IL299870A/en unknown
- 2021-07-15 CN CN202180062742.5A patent/CN116209671A/zh active Pending
- 2021-07-15 EP EP21742144.5A patent/EP4182023A1/en active Pending
- 2021-07-15 AU AU2021309548A patent/AU2021309548A1/en active Pending
-
2023
- 2023-02-09 CO CONC2023/0001411A patent/CO2023001411A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7819087B2 (ja) | インターロイキン-23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 | |
| ES2391974T3 (es) | Procedimientos y composiciones para el tratamiento de trastornos gastrointestinales | |
| CN101687006B (zh) | 具有改善特性的重建表面活性剂 | |
| TW202515892A (zh) | 介白素-23受體之肽抑制劑及其治療發炎性疾病之用途 | |
| JP7637965B2 (ja) | 5.8~8.5のpIを有する少なくとも1つの基礎インスリンならびにカルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むpH7の注射溶液 | |
| JP2024059696A (ja) | 5.8~8.5のpIを有する少なくとも1つの基礎インスリンならびにカルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むpH7の注射溶液 | |
| JP2016501204A5 (cg-RX-API-DMAC10.html) | ||
| JP2011184442A (ja) | Il−21の誘導体 | |
| TW202317604A (zh) | 用於治療遺傳性血鐵沉積症之鐵調素模擬物 | |
| ZA200106530B (en) | Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant. | |
| TW200824705A (en) | Reconstituted surfactants having improved properties | |
| CN110229216A (zh) | 具有改善的药代动力学性质的坎普他汀类似物 | |
| JP2014516037A5 (cg-RX-API-DMAC10.html) | ||
| JP2022545916A5 (cg-RX-API-DMAC10.html) | ||
| WO2018128828A1 (en) | Novel hepcidin mimetics and uses thereof | |
| CN103946233A (zh) | 多黏菌素衍生物 | |
| RU2593757C2 (ru) | Пептиды, выделенные из человеческого лактоферрина, и их применение | |
| TW202140073A (zh) | 玻尿酸衍生物、醫藥組合物及玻尿酸衍生物-藥物結合體 | |
| JP2022535556A (ja) | Glp1/2二重アゴニストの非経口医薬組成物 | |
| JP6998878B2 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| CN114599389A (zh) | 变体fc结构域及其用途 | |
| JP2018531284A6 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| JPWO1995015980A1 (ja) | 新規な合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤 | |
| ES2368565T3 (es) | Péptidos y composiciones medicinales que contienen los mismos. | |
| JP2026515377A (ja) | 神経系修復のためのタンパク質チロシンホスファターゼ楔ドメインペプチドダイマー |